Annual Current Liabilities
$31.60 M
+$644.00 K+2.08%
December 1, 2024
Summary
- As of March 13, 2025, ACRS annual total current liabilities is $31.60 million, with the most recent change of +$644.00 thousand (+2.08%) on December 1, 2024.
- During the last 3 years, ACRS annual current liabilities has risen by +$8.66 million (+37.79%).
- ACRS annual current liabilities is now at all-time high.
Performance
ACRS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$31.60 M
+$12.78 M+67.92%
December 1, 2024
Summary
- As of March 13, 2025, ACRS quarterly total current liabilities is $31.60 million, with the most recent change of +$12.78 million (+67.92%) on December 1, 2024.
- Over the past year, ACRS quarterly current liabilities has increased by +$644.00 thousand (+2.08%).
- ACRS quarterly current liabilities is now -26.09% below its all-time high of $42.75 million, reached on June 30, 2019.
Performance
ACRS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ACRS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.1% | +2.1% |
| 3 y3 years | +37.8% | +37.8% |
| 5 y5 years | +40.9% | +53.4% |
ACRS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.0% | at high | +101.5% |
| 5 y | 5-year | at high | +112.4% | at high | +147.1% |
| alltime | all time | at high | +8509.3% | -26.1% | +2118.8% |
Aclaris Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $31.60 M(+2.1%) | $31.60 M(+67.9%) |
| Sep 2024 | - | $18.82 M(+20.0%) |
| Jun 2024 | - | $15.68 M(-21.9%) |
| Mar 2024 | - | $20.08 M(-35.1%) |
| Dec 2023 | $30.95 M(+41.1%) | $30.95 M(+13.3%) |
| Sep 2023 | - | $27.32 M(+19.7%) |
| Jun 2023 | - | $22.83 M(+25.0%) |
| Mar 2023 | - | $18.26 M(-16.8%) |
| Dec 2022 | $21.94 M(-4.3%) | $21.94 M(+10.9%) |
| Sep 2022 | - | $19.79 M(+22.0%) |
| Jun 2022 | - | $16.22 M(-3.0%) |
| Mar 2022 | - | $16.73 M(-27.1%) |
| Dec 2021 | $22.93 M(+54.2%) | $22.93 M(+28.5%) |
| Sep 2021 | - | $17.84 M(+19.6%) |
| Jun 2021 | - | $14.92 M(+2.8%) |
| Mar 2021 | - | $14.51 M(-2.5%) |
| Dec 2020 | $14.87 M(-33.7%) | $14.87 M(+16.3%) |
| Sep 2020 | - | $12.79 M(-27.9%) |
| Jun 2020 | - | $17.75 M(-13.9%) |
| Mar 2020 | - | $20.60 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $22.43 M(-18.0%) | $22.43 M(-42.5%) |
| Sep 2019 | - | $38.99 M(-8.8%) |
| Jun 2019 | - | $42.75 M(+18.0%) |
| Mar 2019 | - | $36.23 M(+32.5%) |
| Dec 2018 | $27.34 M(+114.2%) | $27.34 M(+22.7%) |
| Sep 2018 | - | $22.28 M(+11.0%) |
| Jun 2018 | - | $20.07 M(+45.2%) |
| Mar 2018 | - | $13.82 M(+8.3%) |
| Dec 2017 | $12.76 M(+105.1%) | $12.76 M(+27.7%) |
| Sep 2017 | - | $9.99 M(+19.4%) |
| Jun 2017 | - | $8.37 M(+48.5%) |
| Mar 2017 | - | $5.64 M(-9.4%) |
| Dec 2016 | $6.22 M(+300.2%) | $6.22 M(+35.5%) |
| Sep 2016 | - | $4.59 M(-16.6%) |
| Jun 2016 | - | $5.51 M(+47.7%) |
| Mar 2016 | - | $3.73 M(+139.8%) |
| Dec 2015 | $1.55 M(+7.2%) | $1.55 M(-18.0%) |
| Sep 2015 | - | $1.90 M(+33.2%) |
| Jun 2015 | - | $1.42 M(-1.9%) |
| Dec 2014 | $1.45 M(+295.4%) | $1.45 M |
| Dec 2013 | $367.00 K | - |
FAQ
- What is Aclaris Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual current liabilities year-on-year change?
- What is Aclaris Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly current liabilities year-on-year change?
What is Aclaris Therapeutics annual total current liabilities?
The current annual current liabilities of ACRS is $31.60 M
What is the all time high annual current liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual total current liabilities is $31.60 M
What is Aclaris Therapeutics annual current liabilities year-on-year change?
Over the past year, ACRS annual total current liabilities has changed by +$644.00 K (+2.08%)
What is Aclaris Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ACRS is $31.60 M
What is the all time high quarterly current liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly total current liabilities is $42.75 M
What is Aclaris Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ACRS quarterly total current liabilities has changed by +$644.00 K (+2.08%)